Apply on Employer Site

Cell Signaling Technology (CST) · 14 hours ago

Lab Internship

Greater Boston

Internship

Onsite

Intern

$17/hr - $18/hr

Start in 2026 Spring

Cell Signaling Technology, Inc. (CST) is a worldwide leader in developing and commercializing antibodies, assays, and research tools. They are offering hands-on laboratory internship opportunities for undergraduate students in various departments, allowing them to gain valuable skills and experience in a laboratory setting.

Biotechnology

Growth Opportunities

H1B Sponsor Likely

Responsibilities

Cell culture

Molecular biology responsibilities, such as cloning, PCR, peptide conjugation, etc

SDS-PAGE, western blot analysis, immunoprecipitation, immunofluorescence, etc

Preparation of media and buffers

Validation of monoclonal antibodies for use in Immunohistochemistry or Flow Cytometry

Antibody engineering, epitope mapping, purification and validation

Qualification

Cell cultureMolecular biologySDS-PAGEWestern blot analysisCommunication skillsCollaborative skills

Required

Must be currently enrolled in an Undergraduate program in Biological or Chemistry related science

Should possess a passion for technology, science, and learning

Exhibit strong communication and collaborative skills

Company

Cell Signaling Technology (CST)

Founded by research scientists in 1999, Cell Signaling Technology (CST) is a private, family-owned company that prides itself on operating as a research institute developing quality products for other researchers.

Founded in 1999

Danvers, Massachusetts, USA

501-1000 employees

https://www.cellsignal.com

H1B Sponsorship

Cell Signaling Technology (CST) has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)

Distribution of Different Job Fields Receiving Sponsorship

Represents job field similar to this job

Trends of Total Sponsorships

2024 (2)

2023 (3)

2021 (6)

2020 (1)